KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Interest Coverage Ratio (2018 - 2020)

Historic Interest Coverage Ratio for Xenon Pharmaceuticals (XENE) over the last 4 years, with Q2 2020 value amounting to 4.19.

  • Xenon Pharmaceuticals' Interest Coverage Ratio rose 8543.47% to 4.19 in Q2 2020 from the same period last year, while for Mar 2021 it was 255.37, marking a year-over-year decrease of 81842.84%. This contributed to the annual value of 64.67 for FY2020, which is 11658.36% down from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 4.19 for Q2 2020, which was up 8543.47% from 24.34 recorded in Q1 2020.
  • Xenon Pharmaceuticals' 5-year Interest Coverage Ratio high stood at 4.19 for Q2 2020, and its period low was 49.09 during Q1 2018.
  • Over the past 3 years, Xenon Pharmaceuticals' median Interest Coverage Ratio value was 28.8 (recorded in 2019), while the average stood at 28.46.
  • As far as peak fluctuations go, Xenon Pharmaceuticals' Interest Coverage Ratio tumbled by 1785.14% in 2019, and later skyrocketed by 8543.47% in 2020.
  • Over the past 3 years, Xenon Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 20.92 in 2018, then plummeted by 59.28% to 33.33 in 2019, then skyrocketed by 87.41% to 4.19 in 2020.
  • Its Interest Coverage Ratio stands at 4.19 for Q2 2020, versus 24.34 for Q1 2020 and 33.33 for Q4 2019.